Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome

NCT07136454 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Angelman Syndrome

Interventions

DRUG: Rugonersen

Sponsor

Oak Hill Bio Ltd

Collaborators

[object Object]